Use of fosinopril to reduce cardiovascular events in disalysis patients

摘要

The invention relates to the use of fosinopril or a pharmaceutically acceptable salt thereof, to reduce the risk of occurrence of a cardiovascular event in dialysis patients, in particular blood dialysis patients, especially patients presenting left-ventricular hypertrophy.